NCT00729157 2017-03-15Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine TherapyNational Cancer Institute (NCI)Phase 2 Completed41 enrolled 10 charts